American Gastroenterological Association

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

Retrieved on: 
Donnerstag, Mai 9, 2024
DDW, Abstract (summary), American Gastroenterological Association, Gastrointestinal disease, SAN

SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present clinical and preclinical and data on the RaniPill® capsule, the company’s oral delivery platform, at Digestive Disease Week® (DDW) taking place both virtually and in-person on May 18-21, 2024 in Washington, DC.

Key Points: 
  • SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present clinical and preclinical and data on the RaniPill® capsule, the company’s oral delivery platform, at Digestive Disease Week® (DDW) taking place both virtually and in-person on May 18-21, 2024 in Washington, DC.
  • Details of the presentations are as follows:
    Abstracts selected by the American Gastroenterological Association (AGA) for presentation at DDW will be available in a supplement to Gastroenterology.
  • The presentations and information about DDW 2024 may be accessed at https://ddw.org/ .

Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024

Retrieved on: 
Montag, Mai 6, 2024
DDW, Abstract (summary), Serri, Sardinia, American Gastroenterological Association

Abstracts selected by the American Gastroenterological Association (AGA) for presentation at DDW will be available in a supplement to Gastroenterology.

Key Points: 
  • Abstracts selected by the American Gastroenterological Association (AGA) for presentation at DDW will be available in a supplement to Gastroenterology.
  • All information presented at DDW, including poster presentations, is embargoed until 12:01 AM Eastern on the day of the presentation.
  • The poster presentation will be made available on the Biora Therapeutics website following the meeting.

89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH

Retrieved on: 
Donnerstag, Mai 2, 2024
Infection, MASH, Liver disease, Cirrhosis, NAFLD, American Gastroenterological Association, NIH, Publication, Research, Cell Metabolism, Yale University, American Liver Foundation, KOL, Journal of Clinical Pathology, Journal, NASH, Virginia Commonwealth University, Liver, Patient, Fibrosis, AASLD, Internal medicine, Medical Center, Division, SAN, VCU, Pharmaceutical industry

The company will give an overview of the ENLIGHTEN-Cirrhosis trial and the broad commercial opportunity for pegozafermin in advanced MASH.

Key Points: 
  • The company will give an overview of the ENLIGHTEN-Cirrhosis trial and the broad commercial opportunity for pegozafermin in advanced MASH.
  • A replay of the webinar will be accessible in the investors section of 89bio’s website following the event.
  • He has also served as Secretary as well as President of the American Association for the Study of Liver Diseases.
  • He has been continuously funded by the NIH since 1995 and is the principal investigator of four active NIH grants.

Nationally Recognized Health Services Researcher and Entrepreneur Dr. Dena Bravata Joins Vivante Health’s Clinical Advisory Board

Retrieved on: 
Donnerstag, April 11, 2024
Education, Stanford University, Palo Alto, California, State, Castlight Health, American College, American Gastroenterological Association, Hospital, CDC, Internal medicine, Advisory board, White, GI, Patient, Work, Physician, Harvard Medical School, Associate, Massachusetts General Hospital, Nursing

CHICAGO, April 11, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced today the addition of Dr. Dena Bravata to its Clinical Advisory Board.

Key Points: 
  • CHICAGO, April 11, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced today the addition of Dr. Dena Bravata to its Clinical Advisory Board.
  • She joins a growing team of internationally recognized experts and physician leaders committed to advancing GI care.
  • Dr. Bravata is a healthcare entrepreneur, executive, and nationally recognized health services researcher.
  • “Vivante Health’s dedication to clinical rigor and use of technology-enabled services in the thoughtful care of patients with digestive health issues excites me,” said Dr. Bravata.

Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board

Retrieved on: 
Montag, Februar 26, 2024
Research, American Gastroenterological Association, Inflammatory Bowel Diseases, Education, Colorectal cancer, Physician, Quality of life, Hospital, Epidemiology, Gastrointestinal cancer, Vivante Corporation, American College, Inflammatory bowel disease, Associate, Massachusetts General Hospital, Harvard Medical School, Stanford University Medical Center, State, Nursing

CHICAGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced the addition of Dr. Hamed Khalili to its Clinical Advisory Board today.

Key Points: 
  • CHICAGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Vivante Health , the employee benefit for GI care, announced the addition of Dr. Hamed Khalili to its Clinical Advisory Board today.
  • Dr. Khalili is a gastroenterologist and Director of Clinical Research at Massachusetts General Hospital, Crohn’s and Colitis Center and an Associate Professor at Harvard Medical School.
  • His research focuses on studying dietary and lifestyle factors and their relationship to the development and progression of inflammatory bowel diseases.
  • “Vivante Health is doing fantastic work to care for people with digestive conditions, particularly in the area of inflammatory bowel disease and other digestive conditions.

EMC Outdoor Announces the Addition of Dana Johnston as Vice President, Client Partnerships

Retrieved on: 
Dienstag, März 5, 2024
PAR, American Gastroenterological Association, McLarney, EMC, PCMA, ASAE, Organization, IDSA, Corporation

PHILADELPHIA, March 5, 2024 /PRNewswire/ -- EMC Outdoor is pleased to announce the appointment of industry veteran Dana Johnston as Vice President, Client Partnerships.

Key Points: 
  • Industry veteran Dana Johnston joins long-standing Out of Home and conference marketing specialist agency EMC Outdoor as Vice President, Client Partnerships.
  • PHILADELPHIA, March 5, 2024 /PRNewswire/ -- EMC Outdoor is pleased to announce the appointment of industry veteran Dana Johnston as Vice President, Client Partnerships.
  • Dana will help to strengthen our position as a leader in the industry and accelerate the development of key client relationships."
  • In her new role, Johnston will focus on developing new client relationships, expanding EMC's client portfolio, and driving success for her clients.

Peak Gastroenterology Associates Opens a New State-of-the-Art Facility to Better Serve the Denver Area

Retrieved on: 
Donnerstag, November 16, 2023
General Health, Other Health, Hospitals, Health, Practice Management, CO, American Gastroenterological Association, Peak, Patient, Nursing

Peak Gastroenterology Associates (“Peak” or “the Company”) is pleased to announce the grand opening of a new location in Lone Tree, CO.

Key Points: 
  • Peak Gastroenterology Associates (“Peak” or “the Company”) is pleased to announce the grand opening of a new location in Lone Tree, CO.
  • The general office and clinic will begin to see patients on November 16th and the connected endoscopy center is slated to open in late December.
  • The new space has specifically been designed to prioritize patient comfort, access, and convenience.
  • Peak, the fastest growing and largest gastroenterology practice in Southern Colorado, is a preferred partner of Gastro Care Partners.

Oshi Health Announces Agreement with WTW to Give Employers Access to Comprehensive Digestive Health Support for Their Employees

Retrieved on: 
Mittwoch, Dezember 6, 2023
WTW, 24/7 service, Food, Investment, Doctor of Pharmacy, American Gastroenterological Association, Patient, Clinical trial, Oshi, Aircraft, GI, Chantelle, Diagnosis, Partnership, ACG, Physician, Nursing

NEW YORK, Dec. 6, 2023 /PRNewswire-PRWeb/ -- With digestive health steadily increasing as a top cost category and growing concern among employers, Oshi Health, the virtual gastrointestinal (GI) clinic, today announces a partnership with WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company. Recognizing that digestive health issues are becoming a major cost issue and the quality of care is uneven, WTW embarked on a market analysis of solutions available and selected Oshi as a digestive health partner for WTW clients.

Key Points: 
  • Recognizing that digestive health issues are becoming a major cost issue and the quality of care is uneven, WTW embarked on a market analysis of solutions available and selected Oshi as a digestive health partner for WTW clients.
  • As a virtual GI center of excellence, Oshi Health provides employers with a total digestive health solution, delivering high-touch multidisciplinary care virtually and in partnership with local in-person providers to speed time to diagnosis, treatment, and symptom control.
  • They also demonstrated the transformational role employers can play in employees' digestive health and overall wellbeing by providing the program.
  • With Oshi, WTW clients will have easy access to digestive care that has been proven effective.

Gastroenterology Associates of North Mississippi Expands Access to GI Healthcare in Northern Mississippi through Partnership with Panola Medical Center.

Retrieved on: 
Freitag, Dezember 1, 2023
Health, American Gastroenterological Association, Patient, Gastroenterology, Travel, Partnership, Nursing

BATESVILLE, Miss., Dec. 1, 2023 /PRNewswire/ -- Gastroenterology Associates of North Mississippi (GANM) is excited to announce the expansion of its services to Panola Medical Center effective January 1st, 2024.

Key Points: 
  • BATESVILLE, Miss., Dec. 1, 2023 /PRNewswire/ -- Gastroenterology Associates of North Mississippi (GANM) is excited to announce the expansion of its services to Panola Medical Center effective January 1st, 2024.
  • The choice to extend services at Panola Medical Center reflects GANM's commitment to prioritizing local community care and accessibility.
  • Panola Medical Center CEO, Chris Ware, expressed enthusiasm for this partnership, stating, "We are thrilled to welcome Gastroenterology Associates of North Mississippi to Panola Medical Center.
  • This partnership with Panola Medical Center reflects GANM's longstanding mission to offer the highest quality healthcare within a compassionate, respectful, and caring environment.

Intoleran Prioritizes a Clean Digestive Enzyme Manufacturing Process

Retrieved on: 
Donnerstag, November 30, 2023
Enzyme, Starch, Digestion, HPMC, Research, Stomach, American Gastroenterological Association, Bloating, Fructose, Food intolerance, Crohn's disease, Calcium carbonate, Lactase, Nausea, Lactose, Extrapyramidal system, Animal feed, Dairy

FORT LAUDERDALE, Fla., Nov. 30, 2023 /PRNewswire/ -- There are many reasons an individual might struggle with digestive concerns. In 2022, the American Gastroenterological Association (AGA) reported new research revealing that as much as 40% of Americans suffer from "digestive troubles" on a daily basis. At times, this can be severe and can stem from serious medical concerns, such as celiac disease or Crohn's disease.

Key Points: 
  • "Food intolerance is typically a lack of digestive enzymes in the body," explains Harmen Treep, owner of Intoleran.
  • However, to be effective, enzymes must be clean and should not contain ingredients that complicate digestive issues.
  • "If a digestive enzyme comes with a lengthy ingredients list on the bottle, think twice," Treep warns.
  • The Intoleran owner uses his brand's lactase 10,000 digestive enzyme capsules as an example.